Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice

Molecular and Cellular Biochemistry

Volumn 209, Issue 1-2, 2000, Pages 125-129

  Srivastava, Rai Ajit K ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Esperion Therapeutics Inc   (United States)

Author keywords

Apolipoprotein A I; Apolipoprotein E; Gene expression; Transgenic mouse

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E;

ARTICLE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SYNTHESIS; LIVER CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSGENE;

EID: 0033935372     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007107712725     Document Type: Article

References (26)

1. Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa C, Takaku F, Yazaki Y: Overexpression of apolipoprotein E in transgenic mice: Marked reduction in plasma lipoproteins except high density lipoproteins and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci USA 89: 1750-1754, 1992
2. Smith JD, Plump AS, Hayek T, Walsh A, Breslow JL: Accumulation of human apolipoprotein E in the plasma of transgenic mice. J Biol Chem 265: 14709-14712, 1990
3. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM: Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature 353: 265-267, 1991
4. 3. J Biol Chem 264: 6488-6494, 1989
5. Innerarity TL, Mahley RW: Enhanced binding of cultured human fibroblasts of apoE-containing lipoproteins as compared with low density lipoproteins. Biochemistry 17: 1440-1447, 1978
6. Zhang W, Gaynor PM, Kruth HS: Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 271: 28641-28646, 1996
7. Zhang S, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992
8. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353, 1992
9. Sorci-Thomas M, Prack MM, Dashti N, Johnson F, Rudel LL, Williams DL: Apolipoprotein (apo) A-I production and mRNA abundance explain plasma apoA-I and high density lipoprotein differences between two non-human primate species with high and low susceptibilities to diet-induced hypercholesterolemia. J Biol Chem 263: 5183-5189, 1988
10. Miller GJ, Miller NE: Plasma high density lipoproteins and the development of ischaemic heart disease. Lancet I: 16-19, 1975
11. Srivastava RAK, Tang J, Krul ES, Pfleger B, Kitchens RT, Schonfeld G: Dietary fatty acids and dietary cholesterol differ in their effects on the in vivo regulation of apoA-I and A-II gene expression. Biochim Biophys Acta 1125: 251-261, 1992
12. Srivastava RAK, Baumann D, Schonfeld G: Regulation of low density lipoprotein receptor by estrogen differs in rat and mouse. Eur J Biochem 216: 527-538.
13. Strobl W, Chan L, Patsch W: Differential regulation of hepatic apolipoprotein A-I and A-II gene expression by thyroid hormone in rat liver. Atherosclerosis 97: 161-170, 1993
14. Paszty C, Maeda N, Verstuyft JG, Rubin EM: Apolipoprotein A-I transgene corrects apolipoprtoein E deficiency-induced atherosclerosis in mice. J Clin Invest 94: 899-903, 1994
15. Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H: Lipoprotein[a] in health and disease. Crit Rev Clin Lab Sci 33: 495-543, 1996
16. Liu AC, Lawn RM, Verstuyft JG, Rubin EM: Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J Lipid Res 35: 2263-2267, 1994
17. deSilva HV, Mas-Oliva J, Taylor JM, Mahley RW: Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein-rich high density lipoproteins in the mouse. J Lipid Res 35: 1297-1310, 1994
18. Srivastava RAK, Jiao S, Tang J, Pfleger B, Kitchens RT, Schonfeld G: In vivo regulation of low density lipoprotein receptor and apolipoprotein B gene expression by dietary fat and cholesterol in inbred strains of mice. Biochim Biophys Acta 1086: 29-43, 1991
19. Srivastava RAK, Srivastava N, Schonfeld G: Expression of low density lipoprotein receptor, apolipoprotein A-I, apolipoprotein A-II, and apolipoprotein A-IV in various rat organs utilizing an efficient and rapid method of RNA isolation. Biochem Intern 27: 85-95, 1992
20. Srivastava RAK: Using riboprobes for Northern blotting analysis. Meth Mol Biol 86: 103-112, 1998
21. Srivastava RAK, Pfleger B, Schonfeld G: Expression of low density lipoprotein receptor, apolipoprotein B, apolipoprotein A-I, and apolipoprotein A-IV messenger RNA in various mouse organs as determined by a novel RNA-excess solution hybridization assay. Biochim Biophys Acta 1090: 95-101, 1991
22. Srivastava RAK: Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and posttranscriptional mechanisms. Mol Cell Biochem 155: 153-162, 1996
23. Srivastava RAK, Srivastava N, Averna A, Lin RC, Korach K, Lubahn D, Schonfeld G: Estrogen upregulates apolipoprotein E (apoE) gene expression by increasing apoE mRNA in the translating pool via the estrogen receptor α-mediated pathway. J Biol Chem 272: 33360-33366, 1997
24. Srivastava RAK: Dietary saturated fat, but not cholesterol, regulates apolipoprotein A-I gene expression by posttranscriptional mechanism. Biochem Mol Biol Intern 34: 393-402, 1994
25. Azrolan N, Odaka H, Breslow JL, Fischer EA: Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool. J Biol Chem 270: 19833-19838, 1995
26. Williamson R, Lee D, Hagaman J, Maeda N: Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad USA 89: 7134-7138, 1992